Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
UEC filed its quarterly report on June 10, 2024, for the quarter ended April 30, 2024 with the U.S. Securities and Exchange Commission. Among other items, UEC reported an adjusted loss per share of $0.05, missing consensus estimates. The Company also reported zero revenues and an operating loss of $13.8 million, compared to revenues of $20 million and an operating loss of $3.5 million for the same period in the prior year.
Following this news, UEC’s stock price dropped over 8% on June 11, 2024.
| Ticker Symbol | Company Name | Join Deadline | Join |
|---|---|---|---|
| SUI | Sun Communities, Inc. | February 10, 2025 | Join |
| SAVA | Cassava Sciences, Inc. | February 10, 2025 | Join |
| APLT | Applied Therapeutics, Inc. | February 18, 2025 | Join |
| BIOA | BioAge Labs, Inc. | March 10, 2025 | Join |
| PCRX | Pacira BioSciences, Inc. | March 14, 2025 | Join |
| NVO | Novo Nordisk A/S | March 25, 2025 | Join |
| GO | Grocery Outlet Holding Corp. | March 31, 2025 | Join |
| NEM | Newmont Corporation | April 01, 2025 | Join |